TORONTO -- (MARKET WIRE) -- December 18, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that Torc Investments and Research LLC, a NASD-registered broker-dealer, reiterated its Buy rating on the Company today and 12-month price target of $3-$3.50.
